Latest from The US Oncology Network

Number One Rankings in 10 Key Performance Areas Reinforce McKesson Specialty Health’s Leading Position in the Oncology and Hematology Market

McKesson’s total solution streamlines MIPS reporting and provides access to custom quality measures, optimizing MIPS performance for community-based oncology practices

Consultants in Medical Oncology and Hematology (CMOH) has joined The US Oncology Network (The Network).

Providers using iKnowMed certified EHR technology are eligible for Quality Performance bonus points under Merit-based Incentive Payment System.

Southern Cancer Center, a premier oncology clinic in Alabama and a practice in The US Oncology Network, is the first site in the world to open enrollment for a new clinical trial for newly diagnosed kidney cancer patients.

Expanded agreement enhances Value Pathways, providing physicians access to the most recent evidence available for five additional disease states.

Jeff Sharman, MD, medical director, Hematology Research, The US Oncology Network, discusses the phase III findings of the GENUINE study, the combination of ublituximab (TG-1101) and ibrutinib (Imbruvica) for patients with previously treated high-risk chronic lymphocytic leukemia (CLL).

Practice with largest infusion treatment center in Delaware gains access to world-class treatments and enhances its cutting-edge research program.